Executive Ha Gi-wan Acquires 1,136 Shares via Open Market Purchase, Stake Rises to 0.01%
Ha Gi-wan (non-registered executive, Pharmaceutical Business Division Head) acquired 1,136 common shares of Raphas through open market purchases from May 22 to June 1, 2026.
Purchase prices were KRW 7,790 (5/22), KRW 7,580 (5/29), and KRW 7,170 (6/1), averaging about KRW 7,496.
This increased Ha's stake from 0% to 0.01%, a minor positive signal as management buys small amounts of stock.
[AI Summary]This routine disclosure of an insider's tiny open-market purchase (0.01% stake change) has no material impact on shareholder value or stock price direction.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders